36C25727Q0058.docx
DOCX document 18 KB Posted
- Solicitation number
- 36C25727Q0058
About this file
This is a Special Notice from the Department of Veterans Affairs, Network Contracting Office (NCO) 17, announcing the intent to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract on a sole-source basis to Natera, Inc. for proprietary molecular genetic reference testing services. The contract will consist of five ordering periods and support the evaluation and monitoring of transplant patients and cancer residual disease at VA facilities within VISN 17 (Texas). The requirement includes two items: Signatera residual disease testing (CPT codes 81479, 81455) with an estimated quantity of 35 units, and Prospera molecular expression transplant assessment testing (CPT code 81479) with an estimated quantity of 25 units.
The solicitation number is 36C25727Q0058, with a response deadline of November 2, 2026, at 10:00 AM CST. This notice explicitly states it is not a request for quotes but rather an informational notice for planning purposes; however, interested parties may submit capability statements demonstrating an ability to perform equivalent proprietary testing. The government retains discretion to compete the requirement despite the stated sole-source intent. Responses must be submitted to Contract Specialist Susan Flores at Susan.Flores2@va.gov. The sole-source justification asserts that Natera is the exclusive provider of these proprietary assays, as no authorized distributors, third-party laboratories, or alternative clinical sources exist for these specialized tests, and only Natera possesses the requisite technology, reagents, and bioinformatics platforms.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Special Notice
| SUBJECT* |
| NEW – STX Specialized Molecular Residual Disease Testing |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 78240 |
| SOLICITATION NUMBER* |
| 36C25727Q0058 |
| RESPONSE DATE/TIME/ZONE |
| 10-30-2026 10AM CENTRAL TIME, CHICAGO, USA |
| ARCHIVE |
| 60 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
| PRODUCT SERVICE CODE* |
| Q301 |
| NAICS CODE* |
| 621511 |
| CONTRACTING OFFICE ADDRESS |
| Department Of Veterans Affairs |
Network Contracting Office 17
5441 Babcock Road Ste. 302 San Antonio TX 78240
POINT OF CONTACT*
Contract Specialist Susan Flores Susan.Flores2@va.gov
(210) 694-6227
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
| *= Required Field |
| Special Notice |
Special Notice
1. NOTICE OF INTENT DESCRIPTION
The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm‑Fixed‑Price contract with five ordering periods on a sole-source basis to:
Natera, Inc.
13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease.
2. SUPPLIES/SERVICES
Item 0001 Description: Signatera Only, CPT Codes 81479, 81455 Estimated Quantity: 35 Unit: Each Item 0002 Description: Prospera, CPT Code 81479 Estimated Quantity: 25 Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including:
• Prospera molecular expression transplant assessment test
• Signatera Residual Disease Test (MRD) (non–liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests.
3. SOLE SOURCE JUSTIFICATION
Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, third‑party laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the necessary technology, reagents, and bioinformatics platforms.
4. THIS NOTICE IS NOT A REQUEST FOR QUOTES
This Special Notice is issued solely for information and planning purposes. It does not constitute a solicitation or a request for competitive quotes.
Interested parties may submit a capability statement demonstrating an ability to perform the required testing. Responses must clearly show that an equivalent proprietary test exists and can be provided.
5. RESPONSE INSTRUCTIONS
Responses must be emailed to:
Susan Flores Contract Specialist, NCO 17 Email: Susan.Flores2@va.gov
Deadline: November 2, 2026 at 10:00 AM CST
The Government will review all responses but retains discretion regarding whether to compete this requirement. The Government is not responsible for any costs incurred in responding to this notice.
6. PLACE OF PERFORMANCE
VA Facilities within VISN 17 (Texas) Specific ordering locations will be identified in individual task/delivery orders.
7. PERIOD OF PERFORMANCE
Five ordering periods (exact dates to be determined at award).
| *= Required Field |
| Special Notice |
Page 1 of
Special Notice
File details come from the government source that posted it. Updated .